Referințe:
1. Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec. 2014;89(25):265-287.
2. Gnann JR Jr. Chapter 65: Antiviral therapy of varicella-zoster virus infections. https://www.ncbi.nlm.nih.gov/books/NBK47401/. Accesat la data de 8 august 2018.
3. European Centre for Disease Prevention and Control (ECDC). Factsheet about varicella. https://ecdc.europa.eu/en/varicella/facts. Accesat la data de 8 august 2018.
4. VARIVAX™ [VACCIN VARICELIC CU VIRUSURI VII (Oka/Merck)]. Rezumatul Caracteristicilor Produsului, ianuarie 2018.
5. Centers for Disease Control and Prevention (CDC). Chickenpox (varicella): managing people at risk for severe varicella. https://www.cdc.gov/chickenpox/hcp/persons-risk.html. Accesat în data de 8 august 2018.
6. Public Health England. Guidance for issuing varicella-zoster immunoglobulin (VZIG). https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/724861/VZIG_Guidance_Version_7_August_2017.pdf. Accesat la data de 8 august 2018.
7. Tunbridge AJ, Breuer J, Jeffery KJ; for British Infection Society. Chickenpox in adults - clinical management. J Infect. 2008;57(2):95-102.
8. Kumagai T, Kamada M, Igarashi C, et al. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure. J Infect Dis. 1999;180(3):834-837.
9. Centers for Disease Control and Prevention (CDC). Chickenpox (varicella): prevention & treatment. https://www.cdc.gov/chickenpox/about/preventiontreatment. html. Accesat la data de 8 august 2018.
10. Mustafa MB, Arduino PG, Porter SR. Varicella zoster virus: review of its management. J Oral Pathol Med. 2009;38(9):673-688.